Terri L Warholak1, Michael T Rupp2, Amanda Zale3, Michelle Hines4, Sean Park5. 1. College of Pharmacy, University of Arizona, Tucson, AZ.. Electronic address: warholak@pharmacy.arizona.edu. 2. College of Pharmacy-Glendale, Midwestern University, Glendale, AZ. 3. College of Pharmacy, University of Arizona, Tucson, AZ. 4. PGY2 Emergency Medicine Pharmacy Resident, University of Maryland Medical Center, at time of research, PharmD Candidate, College of Pharmacy, University of Arizona, Tucson, AZ., Baltimore, MD, at time of research, PharmD Candidate, College of Pharmacy, University of Arizona, Tucson, AZ. 5. Albertsons Pharmacy, at time of research, PharmD Candidate, College of Pharmacy, University of Arizona, Tucson, AZ., Tucson, AZ.
Abstract
OBJECTIVE: To recommend incorporation of a prospective drug utilization review (DUR) checklist into the routine processing of prescription orders in the community practice setting to improve the quality and safety of pharmaceutical care. PRACTICE INNOVATION: We proposed a checklist that was designed to include all the elements of a prospective DUR required by the Omnibus Budget Reconciliation Act of 1990 (OBRA '90) and most pharmacy practice acts. CONCLUSION: If properly incorporated into workflow and supported by company policies and procedures, a simple DUR checklist like that proposed in this study could significantly improve the quality of pharmacists' prospective DUR activities and the safety of medication therapy provided to patients. We also recommend that future quality metrics be created and implemented to ensure that pharmacists consistently perform this key professional responsibility.
OBJECTIVE: To recommend incorporation of a prospective drug utilization review (DUR) checklist into the routine processing of prescription orders in the community practice setting to improve the quality and safety of pharmaceutical care. PRACTICE INNOVATION: We proposed a checklist that was designed to include all the elements of a prospective DUR required by the Omnibus Budget Reconciliation Act of 1990 (OBRA '90) and most pharmacy practice acts. CONCLUSION: If properly incorporated into workflow and supported by company policies and procedures, a simple DUR checklist like that proposed in this study could significantly improve the quality of pharmacists' prospective DUR activities and the safety of medication therapy provided to patients. We also recommend that future quality metrics be created and implemented to ensure that pharmacists consistently perform this key professional responsibility.
Authors: Aline de Oliveira Meireles Pires; Maria Beatriz Guimarães Ferreira; Kleiton Gonçalves do Nascimento; Márcia Marques Dos Santos Felix; Patrícia da Silva Pires; Maria Helena Barbosa Journal: Rev Lat Am Enfermagem Date: 2017-08-03